Cipher Pharmaceuticals (CPH) Competitors

Cipher Pharmaceuticals (TSE:CPH) and Cronos Group (TSE:CRON) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, institutional ownership, risk, analyst recommendations, valuation, profitability, earnings, dividends and media sentiment.

Does the media favor CPH or CRON?

In the previous week, Cipher Pharmaceuticals had 18 more articles in the media than Cronos Group. MarketBeat recorded 18 mentions for Cipher Pharmaceuticals and 0 mentions for Cronos Group. Cipher Pharmaceuticals' average media sentiment score of 0.54 beat Cronos Group's score of 0.00 indicating that Cipher Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
Cipher Pharmaceuticals	Positive
Cronos Group	Neutral

Which has preferable valuation and earnings, CPH or CRON?

Cipher Pharmaceuticals has higher earnings, but lower revenue than Cronos Group. Cronos Group is trading at a lower price-to-earnings ratio than Cipher Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cipher Pharmaceuticals	C$19.03M	12.24	C$11.41M	C$0.91	14.33
Cronos Group	C$76.86M	8.97	-C$32.78M	-C$0.18	-14.52

Which has more volatility & risk, CPH or CRON?

Cipher Pharmaceuticals has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500.

Is CPH or CRON more profitable?

Cipher Pharmaceuticals has a net margin of 59.92% compared to Cronos Group's net margin of -42.65%. Cipher Pharmaceuticals' return on equity of 17.93% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cipher Pharmaceuticals	59.92%	17.93%	7.90%
Cronos Group	-42.65%	-4.40%	-3.73%

Do analysts prefer CPH or CRON?

Cipher Pharmaceuticals currently has a consensus target price of C$17.00, indicating a potential upside of 30.97%. Cronos Group has a consensus target price of C$3.54, indicating a potential upside of 35.63%. Given Cronos Group's higher possible upside, analysts plainly believe Cronos Group is more favorable than Cipher Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cipher Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Do insiders and institutionals hold more shares of CPH or CRON?

1.4% of Cipher Pharmaceuticals shares are held by institutional investors. Comparatively, 16.0% of Cronos Group shares are held by institutional investors. 42.0% of Cipher Pharmaceuticals shares are held by company insiders. Comparatively, 46.4% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Does the MarketBeat Community favor CPH or CRON?

Cipher Pharmaceuticals received 112 more outperform votes than Cronos Group when rated by MarketBeat users. Likewise, 62.20% of users gave Cipher Pharmaceuticals an outperform vote while only 50.74% of users gave Cronos Group an outperform vote.

Company	Underperform	Outperform
Cipher Pharmaceuticals	Outperform Votes 181 62.20%	Underperform Votes 110 37.80%
Cronos Group	Outperform Votes 69 50.74%	Underperform Votes 67 49.26%

Summary

Cipher Pharmaceuticals beats Cronos Group on 15 of the 19 factors compared between the two stocks.